155 related articles for article (PubMed ID: 22198346)
1. [Advanced endometrial carcinoma: primary debulking surgery or neoadjuvant chemotherapy?].
Guyon F; Stoeckle E; Thomas L; Petit A; Sire M; Floquet A
Bull Cancer; 2012 Jan; 99(1):43-9. PubMed ID: 22198346
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer.
Bogani G; Ditto A; Leone Roberti Maggiore U; Scaffa C; Mosca L; Chiappa V; Martinelli F; Lorusso D; Raspagliesi F
Tumori; 2019 Feb; 105(1):92-97. PubMed ID: 29984612
[TBL] [Abstract][Full Text] [Related]
3. Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients.
Rabinovich A
Arch Gynecol Obstet; 2016 Jan; 293(1):47-53. PubMed ID: 26288978
[TBL] [Abstract][Full Text] [Related]
4. [Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate].
Segev Y; Gemer O; Auslender R; Lavie O
Harefuah; 2014 Sep; 153(9):527-31, 558. PubMed ID: 25417489
[TBL] [Abstract][Full Text] [Related]
5. Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan.
Eto T; Saito T; Shimokawa M; Hatae M; Takeshima N; Kobayashi H; Kasamatsu T; Yoshikawa H; Kamura T; Konishi I
Gynecol Oncol; 2013 Dec; 131(3):574-80. PubMed ID: 24016406
[TBL] [Abstract][Full Text] [Related]
6. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
[TBL] [Abstract][Full Text] [Related]
7. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
8. JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer.
Nakanishi T; Saito T; Aoki D; Watanabe Y; Ushijima K; Takano M; Sugiyama T; Yaegashi N; Takehara K
Int J Clin Oncol; 2023 Mar; 28(3):436-444. PubMed ID: 36729215
[TBL] [Abstract][Full Text] [Related]
9. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
10. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
11. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
12. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.
Lambrou NC; Gómez-Marín O; Mirhashemi R; Beach H; Salom E; Almeida-Parra Z; Peñalver M
Gynecol Oncol; 2004 Jun; 93(3):653-8. PubMed ID: 15196860
[TBL] [Abstract][Full Text] [Related]
13. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
14. Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
Seward SM; Winer I
Cancer Metastasis Rev; 2015 Mar; 34(1):5-10. PubMed ID: 25597035
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.
de Lange NM; Ezendam NPM; Kwon JS; Vandenput I; Mirchandani D; Amant F; van der Putten LJM; Pijnenborg JMA
Curr Oncol; 2019 Apr; 26(2):e226-e232. PubMed ID: 31043831
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
[TBL] [Abstract][Full Text] [Related]
17. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer.
Pectasides D; Farmakis D; Koumarianou A
Oncology; 2005; 68(1):64-70. PubMed ID: 15809522
[TBL] [Abstract][Full Text] [Related]
18. Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer.
Amant F; Despierre E; Vandenput I
Gynecol Oncol; 2009 Aug; 114(2):370; author reply 370. PubMed ID: 19398127
[No Abstract] [Full Text] [Related]
19. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for ovarian cancer.
Vergote I; van Gorp T; Amant F; Neven P; Berteloot P
Oncology (Williston Park); 2005 Nov; 19(12):1615-22; discussion 1623-30. PubMed ID: 16396153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]